The benefits claimedreversal of aging, improved cognition, enhanced metabolismremain unproven in controlled human trials
Disclosure of interest: All authors: nothing to disclose Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.05 - NEUROINTERVENTION P718 - ESOC25-1019 TIROFIBAN WITH ENDOVASCULAR TREATMENT FOR ACUTE MILD BASILAR ARTERY OCCLUSION STROKE Yongteng Xu 1 , Yibin Xiao 1 , Dong Pan 1 , Xinguang Yang 1 , Songhua Xiao 1 , Yamei Tang 1 1 Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China, Guangzhou, Guangdong Province, China Background and Aims: The effectiveness of tirofiban as an adjunctive treatment for endovascular treatment (EVT) in acute mild basilar artery occlusion (BAO) stroke remains unclear
Q: Why source a co-lyophilized blend instead of individual peptides
The formula Units to draw = (desired dose in mg / concentration in mg per mL) x 100 Let us work through examples at each standard concentration
